Hers Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.6/10
Best for: coverage in all 50 states, which most sellers will not confirm
Hers falls below our bar on oversight: the FDA has issued it a warning letter. Read the breakdown below before you give it money.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Prices checked September 2026
Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.
Is Hers legit?
Hers is a real, operating US company, and the FDA has issued it a warning letter. The letter is summarized at the top of this review. Read what it alleges before you decide, and raise it with the clinician who would prescribe for you. We rate Hers 6.6/10 overall.
Is there a Hers promo or coupon code?
Hers has no code to type in. The current offer: Hers Weight Loss Membership: $39 for the first month, auto-renews at $149/month thereafter (membership billed separately from medication; meds from $149/mo). It applies at checkout on its own. Coupon sites advertising a "Hers promo code" are not a source we can vouch for.
See how Hers compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Hers
Editorial score · methodology
Editorial score · methodology
Embody
Best for: knowing which pharmacy fills the vial: it names RedRock Pharmacy
Editorial score · methodology
Hers at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide
- Starting price
- $199/mo
- What's included
- Medication
- Availability
- All 50 states
- FDA status
- 1 FDA warning letter (details below)
How Hers scores
Six columns, each one computed from something Hers has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
3.0/10The listed figure is not a comparable monthly price for a named GLP-1 (it may be a membership fee, an insured copay, a per-vial rate or a starting-dose price), so Value is capped rather than scored against other sellers.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
5.5/10The FDA has issued it a warning letter. No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
10.0/10Serves 50 of 50 states.
Support10%
3.0/10The price covers the medication.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Hers
Last checked September 2026- Checked the listed price across 2 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Hers
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Hers involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Hers shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Hers which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication.
- Before you commit, get the ongoing monthly price of the medication itself, not a first-month rate, a membership fee or a per-vial price.
- Hers serves all 50 states.
- The FDA has issued Hers a warning letter. It is covered in the enforcement section below; read what it alleges before you decide.
Cancelling Hers
Taken from the terms Hers publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None
- Refund policy
- No refund guaranteed once the pharmacy has processed an order
GLP-1 medications Hers offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)
Check the price yourself before you pay
Every figure here was read off Hers's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
Against it
- Not included in the monthly price: clinician visits, coaching
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Hers a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Hers charges
The standing price at Hers is $199/month.
- Compounded semaglutide: $199/month
- Brand-name tirzepatide: $299/month
HumeCare+, at about $199/month, is the closest like-for-like alternative we review.
What Hers dispenses
Hers prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. You can take the approved brand pen or the cheaper compounded preparation. What separates them is review: the approved product went through it, the compounded one did not, and that is the whole of the trade.
Safety and disclosure
Hers tells you its price before you start the medical questionnaire and that it treats patients in all 50 states. The FDA has issued Hers a warning letter, summarized at the top of this page. A letter flags a problem rather than ruling a seller out, so read what it says before deciding what it means for you. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Hers will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You need insurance to cover the cost. Check whether Hers bills your plan before you start.
- A seller's regulatory history matters to you more than price. Read the warning letter summarized above before deciding.
It fits if
- you need access wherever you live
Our read
Hers charges $199/month. Too few sellers offer the same drug and form to say whether that is cheap or expensive, so judge it on what the package includes. The catch is disclosure, which is why Hers scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you. Whatever you decide, read the warning letter summarized at the top of this page first, and raise it with the clinician who would prescribe for you.
The Bottom Line
Hers falls below our bar on oversight: the FDA has issued it a warning letter. Read the breakdown below before you give it money.
Before you pay Hers
Starting at $199 a month. Check today's price, then start the intake.
Where Hers is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If the standing monthly cost is what decides it, consider Sesame Care (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare Hers head to head
The sellers closest to Hers on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
Hers has an FDA warning letter on record, dated September 9, 2025
This letter concerns unlawful sale of unapproved and misbranded drugs to united states consumers over the internet (telehealth). A warning letter is public correspondence from FDA, not an adjudication. On its own it establishes no finding of illegal activity, and a company that gets one often answers with corrective action.
Sources
Cited across this Hers review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of September 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Hers's current pricing
Plans start at $199 a month. Whether you qualify is a clinician's decision, made after your intake.